Overview
Now in its 44th year, the Chemotherapy Foundation Symposium (CFS®) brings together thousands of health care professionals for an exciting 3-day conference that promotes the delivery of evidence-based, state-of-the-art cancer care. Internationally renowned faculty will provide you with expert insights on the latest developments in cancer therapeutics, offering a unique opportunity to learn how innovative approaches fit into existing treatment paradigms to optimize clinical care for your patients with cancer.
Exciting new developments and rapid changes continue to occur in the management of solid and hematologic malignancies. In the past year, practice-changing diagnostic, therapeutic, and supportive care strategies have entered clinical practice, and many more are poised to do so. Optimized testing and treatments for early and advanced disease, including chemotherapeutics, targeted therapies, immunotherapies—alone and in combination—and multimodal strategies continue to improve clinical outcomes. CFS® offers you the critical knowledge you need to safely and effectively integrate these strategies into your practice.
Learning Objectives
Upon completion of this activity, learners will be better able to:
- Describe the supporting evidence for novel biomarker-testing approaches that guide the use of targeted therapies and/or modification of treatment plans
- Evaluate efficacy and safety data from recent pivotal trials investigating new and emerging therapies
- Develop personalized treatment plans based on evolving evidence, guideline recommendations, and individual patient/disease characteristics
- Apply strategies to identify and mitigate treatment-related adverse effects associated with novel therapies and combination regimens
Program Co-Chairs
Benjamin P. Levy, MD |
John O. Mascarenhas, MD |
Tiffany A. Traina, MD, FASCO |
To view full profile, click on the Program Co-Chairs tab above.
Benjamin P. Levy, MD
Associate Professor of Oncology
Johns Hopkins University School of Medicine
Clinical Director of Medical Oncology
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Sibley Memorial Hospital
Washington, DC
John O. Mascarenhas, MD
Director, Center of Excellence in Blood Cancers and Myeloid Disorders
Professor of Medicine
Icahn School of Medicine at Mount Sinai
The Tisch Cancer Institute
New York, NY
Tiffany A. Traina, MD, FASCO
Associate Attending Physician
Vice Chair, Oncology; Department of Medicine
Section Head, Triple Negative Breast Cancer Clinical Research Program
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine, Weill Cornell Medicine
New York, NY
Click the button below to view all faculty presenters.
Physicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC designates this live activity for a maximum of 12.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC is approved by the California Board of
Registered Nursing, Provider #16669, for 18.0 Contact Hours (Day 1=3.5; Day
2=4.5; Day 3=4.0).
Physicians
Education Resource®, LLC is accredited by the Accreditation Council for
Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This
knowledge-based activity is approved for a maximum of 12.0 contact hours
(12.0 CEUs) under several UAN numbers.
Medical Oncologists (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 12.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Please note: The CE credit/MOC point amounts above include credits/points for
the main session presentations and the Spotlight CE Session.